Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β–Smad3 Pathway

Overview of attention for article published in Frontiers in Pharmacology, July 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (51st percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,787 followers.

RT @FrontPharmacol: New Research: Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β–Smad3 Pathway https:/…

New Research: Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β–Smad3 Pathway https://t.co/8hJPXLPxhg #pharmacology

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.